Fund Name | Location |
Axa Deutschland | - |
Bank Leumi | Israel, Tel Aviv, Tel Aviv District |
Binder & Partners Ventures | France, Ile-de-France, Paris |
Dazi Dingcheng Ziben | - |
dGav Capital | China, Shanghai |
Global Blue | Eysins, Geneve, Switzerland |
Helen Ventures | Finland, Helsinki, Southern Finland |
Internet Holding A.S | - |
Lafayette Square | New York, New York, United States |
NEOTEC | Kent, Ohio, United States |
Quest Venture Partners | California, Palo Alto, United States |
Radicle Impact | California, Oakland, United States |
San Jose State University | California, San Jose, United States |
Shanghai Kinetic Medical | China, Pudong |
StubHub | California, San Francisco, United States |
Tribeca Angels | New York, New York, United States |
Yijun Touzi | China, Hangzhou, Zhejiang |
Yunnan Nantian Electronics Information | China, Kunming, Yunnan |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Abacus Bioscience | $4M | 01 Feb 2023 | Seattle, Washington, United States | ||
UNUM Therapeutics | $65M | 11 Jun 2015 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Abacus Bioscience | $4M | 01 Feb 2023 | Seattle, Washington, United States | ||
UNUM Therapeutics | $65M | 11 Jun 2015 | Cambridge, Massachusetts, United States |